当前位置:首页 - 行情中心 - 新华医疗(600587) - 财务分析

新华医疗

(600587)

  

流通市值:110.23亿  总市值:111.08亿
流通股本:6.02亿   总股本:6.07亿

新华医疗(600587)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.34亿元,每股收益1.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益790255.70万元,未分配利润389990.30万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1538922.02万元,负债748666.32万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入7,423,276,804.995,186,552,479.092,528,538,840.4310,011,868,423.4
营业总成本6,773,832,366.134,639,584,343.342,298,905,534.939,238,989,522.38
营业利润726,441,151.9565,515,818.18238,345,015.56756,953,382.55
利润总额724,080,458.36567,473,647.79240,004,730.67738,579,127.23
净利润633,953,374.65498,059,342.32215,024,150.02676,501,383.22
其他综合收益62,894.1362,894.13-21,899
综合收益总额634,016,268.78498,122,236.45215,024,150.02676,523,282.22
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计9,367,034,360.259,423,737,732.029,317,526,660.999,454,331,945.33
非流动资产合计6,022,185,854.766,129,247,300.26,129,431,088.716,135,997,829.9
资产总计15,389,220,215.0115,552,985,032.2215,446,957,749.715,590,329,775.23
流动负债合计7,135,759,705.247,282,566,664.337,187,907,892.357,517,191,418.31
非流动负债合计350,903,477.67347,151,175.54394,044,269.05353,302,686.34
负债合计7,486,663,182.917,629,717,839.877,581,952,161.47,870,494,104.65
归属于母公司股东权益合计7,485,939,780.057,508,040,905.527,463,912,619.537,318,625,200.44
股东权益合计7,902,557,032.17,923,267,192.357,865,005,588.37,719,835,670.58
负债和股东权益合计15,389,220,215.0115,552,985,032.2215,446,957,749.715,590,329,775.23
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计7,182,115,065.894,783,687,013.262,244,699,365.8710,845,828,221
经营活动现金流出小计7,218,274,093.84,646,429,137.162,458,602,116.599,815,713,741.83
经营活动产生的现金流量净额-36,159,027.91137,257,876.1-213,902,750.721,030,114,479.17
投资活动现金流入小计140,738,135.82121,378,932.4767,221,719.5474,877,961.69
投资活动现金流出小计404,368,059.65283,420,160.27152,917,748.63594,777,005.78
投资活动产生的现金流量净额-263,629,923.83-162,041,227.8-85,696,029.09-519,899,044.09
筹资活动现金流入小计789,732,018.43525,490,554.43388,040,0002,446,244,594.74
筹资活动现金流出小计1,182,578,583.17793,014,274.33480,868,499.521,380,453,956.86
筹资活动产生的现金流量净额-392,846,564.74-267,523,719.9-92,828,499.521,065,790,637.88
汇率变动对现金及现金等价物的影响103,220.43121,616.63-116,290.366,947,499.57
现金及现金等价物净增加额-692,532,296.05-292,185,454.97-392,543,569.691,582,953,572.53
期末现金及现金等价物余额2,348,299,423.672,748,646,264.752,648,288,150.033,040,831,719.72
最新报告期:2024-11-05
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券郑辰,李婵娟1.171.371.702024-11-05
浙商证券孙建,司清蕊1.171.391.672024-10-29
华创证券郑辰,李婵娟1.371.712.112024-09-02
浙商证券孙建,司清蕊1.331.581.872024-08-30
TOP↑